CTVA Stock: Buy or Sell? Price Target & Forecast

CTVA Corteva Inc As of Oct 6, 2026

$12.39

Low reported multiples, but conflicting valuation fields and a wide 52-week range make this a data-verification watchlist.

Setup: Value dislocation / data verification Confidence: low Horizon: 3 months Risk: elevated Category: Mid-cap stock

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals CTVA's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

In a bull scenario, reported P/E of 8.23, price-to-free-cash-flow of 2.95 and a 3.94% daily gain could attract interest if the figures are confirmed. Insider records show more shares bought than sold, but lack dates and transaction context.

▼ Bear Case

The $90.97 52-week high versus $12.39 current price signals an unusually wide range, without a price history to explain it. Reported P/B conflicts with price and book value per share; revenue growth is negative, and cash-flow and balance-sheet statements are missing.

Valuation

Unverified low multiples — score 40/100

Several reported multiples are low, but the P/B conflict and absent statements limit a valuation conclusion.

Technical Levels

Support · $11.74 (Reported day low) · $11.48 (Reported 52-week low)

Resistance · $12.63 (Reported day high)

Financial Health

Score 40/100. Reported liquidity ratios offer limited context; leverage and coverage cannot be assessed.

Catalysts

Third-quarter 2026 earnings release and webcast announced	Date not stated in the supplied headline	Could clarify operating results and reported valuation fields
Potential confirmation of price and P/B data	Unknown	Material to interpreting the apparent valuation gap

Risk Flags

At $12.39, price divided by $35.9199 book value per share is about 0.35, not the reported 1.876 P/B.

The $90.97 52-week high is far above the current price; no price history or corporate-action data explains the gap.

Cash-flow and balance-sheet statements are missing, so reported cash-flow multiples and debt health cannot be verified.

Revenue growth is reported as -0.1 and EPS growth as 0.49, but the payload does not specify their units or periods.

Insider transaction dates, prices and roles are unavailable; sentiment and RSI are also missing.

Illustrative levels and forecasts are price scenarios, not valuation-derived targets; provider data may be delayed or corrected.

See CTVA's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock CTVA free →

More Analyses

RHI

NVDA

AAPL

TSLA

MSFT

AMZN

CTVA FAQ

Is CTVA a buy right now?

Corteva Inc's current read is a Value dislocation / data verification setup with low confidence over a 3 months horizon. Valuation: Unverified low multiples. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is CTVA overvalued?

Unverified low multiples (valuation score 40/100). Several reported multiples are low, but the P/B conflict and absent statements limit a valuation conclusion.

What are the risks of buying CTVA?